ArticleSleep medicine: X2025
Artificial light exposure at night: A hidden risk factor for type 2 diabetes.
Article in Sleep medicine: X, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Blue Light Exposure During Sleep in Type 1 Diabetes: Impacts on Glycemic Control and Psychosocial Health.Journal of sleep research · 2026Trial
- Natural Light Exposure as a Potential 7th Pillar of Lifestyle Medicine.American journal of lifestyle medicine · 2026Article
- Circadian rhythms of gut microbiota modulate nocturnal hyperglycemia in type 2 diabetes: a comprehensive review on mechanisms and chrono-targeted interventions.Frontiers in microbiology · 2026Review
- Technology-driven diabetes care: innovation without equity?Frontiers in digital health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study examines the effect of nighttime light exposure on the risk of developing type 2 diabetes Mellitus (T2DM), highlighting an often-overlooked environmental factor. While lifestyle choices such as diet and physical activity have long been recognized as critical risk factors for T2DM, emerging evidence suggests that artificial light at night (LAN) may also play a significant role. LAN disrupts circadian rhythms, which regulate sleep cycles and glucose metabolism, leading to metabolic dysfunction. Using data from the UK Biobank, researchers assessed the relationship between personal light exposure patterns and T2DM risk. Findings revealed that for every 10-lux increase in LAN, the risk of developing T2DM rises by 30 %. The study underscores the importance of circadian alignment in metabolic health and suggests that mitigating nighttime light exposure, especially in urban environments, could be a practical strategy for reducing T2DM risk. Raising awareness about the health risks of light pollution and advocating for healthier lighting solutions in public spaces could play a crucial role in T2DM prevention. Further research is needed to confirm these findings and explore interventions that reduce nighttime light exposure and its impact on diabetes risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.